Cleveland Clinic’s Endocrinology & Metabolism Institute’s unique model of care, which combines traditional medical endocrinology with bariatric surgery and cardiology, provides deep and broad expertise for the treatment and care of patients with diabetes. Our staff is dedicated to exploring ways to improve the care of these patients and to teaching the best methods for treating them. In recognition of our commitment to excellence, U.S. News and World Report recently named our diabetes and endocrinology services as No. 2 in the nation and the top program in Ohio.
For nearly a century, we have been at the forefront of innovations in diabetes care. In the mid 1920’s, the Cleveland Clinic’s Diabetes House pioneered insulin treatment for diabetes, and Madeline Bebout, an orphan, was the first child to get insulin in Cleveland. In 2012, a team comprised of surgeons, endocrinologists, and physiologists published a landmark study in the New England Journal of Medicine showing that bariatric surgery reverses diabetes. The effect on patients is immediate and independent of surgery-induced weight loss. Current innovations include the development of a bioartificial pancreas to eradicate the need for insulin injections in type 1 diabetes and the creation of mesenchymal stem cells for treatment of type 2 diabetes.